NCT00679640已完成不适用
Observational Usage and Efficacy Study of Candesartan in Heart Failure Treatment in France
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 450
- 试验地点
- 1
- 主要终点
- Profile of patients treated with candesartan for heart failure
研究概览
简要总结
The purpose of this study is to describe the way candesartan is used in heart failure treatment in France (treatment initiation and monitoring), treatment stops occurrence and reasons for and patients clinical evolution
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •outpatients to whom candesartan has been initiated for less than 30 days or during the consultation to treat heart failure
排除标准
- •patients included in a clinical trial the last 30 days before consultation
- •patients unable to answer the questions for linguistic or cognitive reasons
- •patients who will be difficult to follow during the one year study
研究组 & 干预措施
1
Outpatients to whom candesartan has been initiated for less than 30 days or during the consultation to treat heart failure
干预措施: Candesartan (Drug)
结局指标
主要结局
Profile of patients treated with candesartan for heart failure
时间窗: At inclusion
次要结局
- Percentage of patients taking correctly its treatment : indication, contraindication, drug titration, treatment monitoring(6 and 12 months after)
- Percentage of patients stopping its treatment and reasons why(12 months after)
- Percentage of hospitalisations due to heart failure and cardiovascular deaths(12 months after)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
3 期
Candesartan Cilexetil in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM Added)Congestive Heart FailureNCT00634309AstraZeneca597
已完成
3 期
Candesartan Cilexetil in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM Preserved)Congestive Heart FailureNCT00634712AstraZeneca734
已完成
3 期
Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM Alternative)Congestive Heart FailureNCT00634400AstraZeneca6,268
已完成
3 期
Efficacy of Candesartan on Symptomatic Heart Failure in Treating Diabetic and Hypertensive Patients.Heart FailureNCT00775840Takeda22
已完成
不适用
Candesartan Cilexetil / Hydrochlorothiazide Combination Tablets Special Drug Use Surveillance: Long-term Use (12 Months)HypertensionNCT02016183Takeda3,222